Krishna Institute of Medical Sciences (NSE:KIMS) Beneish M-Score: -2.27 (As of Jun. 27, 2026)


NSE:KIMS Krishna Institute of Medical Sciences Ltd NSE:KIMS
87 GF Score
Price ₹795.35
GF Value ₹775.28
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Krishna Institute of Medical Sciences Beneish M-Score?

Krishna Institute of Medical Sciences NSE:KIMS -0.23% 87 Beneish M-Score is -2.27 as of Jun. 27, 2026. GuruFocus rates NSE:KIMS with a GF Score™ of 87/100 and a GF Value™ of ₹775.28 (Fairly Valued). The stock has 7 warning signs investors should review. Among 633 Healthcare Providers & Services companies, Krishna Institute of Medical Sciences ranks worse than 71.25% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.27 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Krishna Institute of Medical Sciences's Beneish M-Score or its related term are showing as below:

NSE:KIMS' s Beneish M-Score Range Over the Past 10 Years
Min: -3.01   Med: -2.33   Max: -1.56
Current: -2.27

During the past 8 years, the highest Beneish M-Score of Krishna Institute of Medical Sciences was -1.56. The lowest was -3.01. And the median was -2.33.


Krishna Institute of Medical Sciences Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Krishna Institute of Medical Sciences's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krishna Institute of Medical Sciences Beneish M-Score Chart

Krishna Institute of Medical Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial -1.56 -2.25 -2.73 -2.39 -2.27

Krishna Institute of Medical Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.39 0.00 0.00 0.00 -2.27

NSE:KIMS vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Krishna Institute of Medical Sciences's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krishna Institute of Medical Sciences Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Krishna Institute of Medical Sciences's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Krishna Institute of Medical Sciences's Beneish M-Score falls into.


NSE:KIMS
87GF Score
Krishna Institute of Medical Sciences Ltd NSE:KIMS
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krishna Institute of Medical Sciences Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Krishna Institute of Medical Sciences for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0081+0.528 * 1.0172+0.404 * 0.9991+0.892 * 1.2865+0.115 * 0.8532
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * -0.034722-0.327 * 1.1542
=-2.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹6,264 Mil.
Revenue was ₹39,046 Mil.
Gross Profit was ₹24,140 Mil.
Total Current Assets was ₹9,374 Mil.
Total Assets was ₹77,587 Mil.
Property, Plant and Equipment(Net PPE) was ₹59,207 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹2,832 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹12,389 Mil.
Long-Term Debt & Capital Lease Obligation was ₹36,374 Mil.
Net Income was ₹2,414 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹5,108 Mil.
Total Receivables was ₹4,830 Mil.
Revenue was ₹30,350 Mil.
Gross Profit was ₹19,086 Mil.
Total Current Assets was ₹6,973 Mil.
Total Assets was ₹57,360 Mil.
Property, Plant and Equipment(Net PPE) was ₹43,723 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1,772 Mil.
Selling, General, & Admin. Expense(SGA) was ₹7,340 Mil.
Total Current Liabilities was ₹8,362 Mil.
Long-Term Debt & Capital Lease Obligation was ₹22,872 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(6264 / 39046) / (4830 / 30350)
=0.160426 / 0.159143
=1.0081

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(19086 / 30350) / (24140 / 39046)
=0.628863 / 0.618245
=1.0172

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (9374 + 59207) / 77587) / (1 - (6973 + 43723) / 57360)
=0.116076 / 0.116179
=0.9991

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=39046 / 30350
=1.2865

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1772 / (1772 + 43723)) / (2832 / (2832 + 59207))
=0.038949 / 0.045649
=0.8532

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 39046) / (7340 / 30350)
=0 / 0.241845
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((36374 + 12389) / 77587) / ((22872 + 8362) / 57360)
=0.628494 / 0.544526
=1.1542

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(2414 - 0 - 5108) / 77587
=-0.034722

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Krishna Institute of Medical Sciences has a M-score of -2.27 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.27 mean?
Krishna Institute of Medical Sciences (NSE:KIMS) has a Beneish M-Score of -2.27 as of Jun. 27, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Krishna Institute of Medical Sciences and its competitors. According to the industry distribution chart, Krishna Institute of Medical Sciences ranks #451 out of 633 companies in the Healthcare Providers & Services industry, placing it in the top 71.2%.
Is Krishna Institute of Medical Sciences' Beneish M-Score too high?
Krishna Institute of Medical Sciences' current Beneish M-Score is -2.27. Based on the distribution chart, Krishna Institute of Medical Sciences ranks #451 out of 633 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Krishna Institute of Medical Sciences ranks #451 out of 633 companies for Beneish M-Score. This places Krishna Institute of Medical Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Krishna Institute of Medical Sciences and its competitors. Krishna Institute of Medical Sciences's current Beneish M-Score is -2.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Fairly Valued. The stock's GF Value™ is ₹775.28, compared to a current price of ₹795.35 — trading 2.6% above its estimated fair value. The current Beneish M-Score is -2.27. Krishna Institute of Medical Sciences' overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current Beneish M-Score is -2.27 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be overvalued. The current stock price of ₹795.35 is trading 2.6% above its estimated GF Value™ of ₹775.28. GuruFocus considers Krishna Institute of Medical Sciences to be Fairly Valued.

Key valuation signals for NSE:KIMS:

  • Beneish M-Score: -2.27
  • GF Value™: ₹775.28 vs. price of ₹795.35 (2.6% above fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krishna Institute of Medical Sciences Business Description

Other Exchanges 543308:India
Address D. No. 1-8-31/1, Minister Road, Secunderabad, TG, IND, 500 003
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
87GF Score

Get the complete analysis for NSE:KIMS

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹795.35
Price
₹775.28
GF Value